Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.045 USD | -1.10% | -1.10% | -41.16% |
05-06 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
04-16 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.16% | 37.32M | |
+5.99% | 111B | |
+11.58% | 106B | |
-12.67% | 22.24B | |
+0.26% | 21.25B | |
-5.06% | 18.97B | |
-35.21% | 18.52B | |
-11.45% | 16.81B | |
+38.07% | 12.54B | |
-24.65% | 8.09B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- SAB Biotherapeutics, Navy Medical Research Command Initiate Safety Study for Influenza Treatment; Shares Decline